Career Enhancement Program (CEP)

Co-Directors: David Mutch, M.D.; Doris Benbrook, PhD, University of Oklahoma; and, Carolyn Muller, M.D., University of New Mexico

Program Application Information

Proposals for the first cycle of the Route 66 Endometrial Cancer SPORE Career Enhancement Program are being accepted until October 27, 2023, at 5 p.m. CST. Review the SPORE CEP Request For Proposals for more information. For additional information, please contact Linda Odibo, RN, MN, SPORE Administrator (odibol@wustl.edu).

SPORE CEP Overview

The goal of the Career Enhancement Program (CEP) is to recruit and support early career and established investigators in translational endometrial cancer research. The CEP builds upon existing productive collaborations between outstanding researchers with expertise in translational endometrial cancer at Washington University, University of New Mexico, and University of Oklahoma. We will further enhance these collaborations by providing funding support, didactic training, career development and mentoring to new investigators in the field.

The CEP will pursue the following specific aims:

  1. Recruit and support the careers of investigators new to endometrial cancer research;
  2. Mentor and advise faculty researchers in translational endometrial cancer research;
  3. Foster collaborations with partner institutions and other endometrial SPORE institutions, and
  4. Promote diverse, equitable, and inclusive participation in endometrial cancer research.

Successful completion of these aims will support new investigators, improve our understanding of the spectrum of endometrial cancer, and develop new approaches for early detection, prevention, and treatment of this prevalent cancer. Our ultimate goal is to build a strong inclusive CEP program that mentors investigators to achieve successful careers in translational endometrial cancer research with the skills to develop an independent SPORE project and vibrant research careers.

man and girl painting a wall
Explore Supportive Care services for your cancer journey Learn More
diabetes
Find out if you’re at risk for diabetes Learn More
See what our commitment to ending diabetes in this century means for you Learn More